Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EIF1P6 is annotated as a pseudogene related to the eukaryotic translation initiation factor 1 (EIF1) gene family. Pseudogenes are DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition and lack regulatory elements or contain disabling mutations that prevent protein expression. As such, EIF1P6 does not produce a functional protein and has no known biological activity, disease relevance, or drug interactions. It is not considered a therapeutic target or a functional molecular entity in current biomedical research or drug discovery. The confusion might occur with related functional genes like EIF1 or EIF6, but EIF1P6 itself is a pseudogene and not a receptor, enzyme, or another target class. No validated roles in disease, therapeutic targeting, or biomarker usage are described for EIF1P6 in current biomedical sources. Its classification is “other” due to its status as a processed pseudogene and not as a functional protein-coding gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 1 pseudogene 6 (EIF1P6).